Wearable Robotic Exoskeleton Market Global Report 2026

The wearable robotic exoskeleton market size has grown exponentially in recent years. It will grow from $1.81 billion in 2025 to $2.26 billion in 2026 at a compound annual growth rate (CAGR) of 24.7%. The growth in the historic period can be attributed to increasing incidence of mobility impairments, rising workplace injury rates, expansion of rehabilitation centers, growing demand for assistive medical devices, and advancements in robotics research.

The wearable robotic exoskeleton market size is expected to see exponential growth in the next few years. It will grow to $5.39 billion in 2030 at a compound annual growth rate (CAGR) of 24.3%. The growth in the forecast period can be attributed to integration of AI-driven motion control, an aging global population, increasing industrial safety regulations, expansion of military modernization programs, and declining costs of robotic components. Major trends in the forecast period include growing adoption of rehabilitation exoskeletons, rising use of exoskeletons in industrial workplaces, increasing demand for powered lower-limb systems, expansion of defense and military applications, and greater focus on lightweight and ergonomic designs.

The rising prevalence of disabilities is expected to propel the growth of the wearable robotic exoskeletons market in the coming years. Disabilities are physical, mental, or sensory impairments that significantly limit an individual's ability to perform daily activities or participate in society. The increase in disabilities can be attributed to several factors, including an aging population, rising chronic health conditions, greater awareness and diagnosis of disabilities, and lifestyle-related issues such as obesity and sedentary behavior. Wearable robotic exoskeletons address the needs of individuals with disabilities by enhancing mobility, providing physical support, facilitating rehabilitation, and improving overall quality of life by enabling users to perform daily activities more independently and safely. For instance, in October 2024, according to the House of Commons Library, a UK-based library and information resource of the lower house of the British Parliament, an estimated 16.1 million people in the UK had a disability in 2022/23, accounting for 24% of the total population. By February 2024, 6.9 million people in Great Britain were claiming extra-costs disability benefits, representing 10.4% of the population. Therefore, the rising prevalence of disabilities is driving the growth of the wearable robotic exoskeletons market.

Major companies operating in the wearable robotic exoskeletons market are developing technologically advanced products, such as lightweight exoskeletons, to reduce user fatigue, improve comfort, and enhance mobility. Lightweight exoskeletons are wearable robotic devices designed to assist movement and provide support while minimizing additional weight, making them easier to wear for extended periods and improving user mobility and comfort. For instance, in June 2023, Comau, an Italy-based company specializing in industrial automation, and IUVO, a US-based company that develops wearable robotics technologies, in collaboration with Esselunga, an Italy-based retail chain, launched the MATE-XB wearable lumbar exoskeleton. The MATE-XB exoskeleton fully supports the lumbosacral joint during bending and lifting activities, enabling workers to safely handle loads of up to 25 kg. This fully passive device improves operator safety and well-being, reflecting Comau’s commitment to wearable robotics by providing both upper- and lower-body support solutions. Additionally, MATE-XB supports sustainable and measurable ergonomic improvements, contributing to long-term health benefits while enhancing the quality and efficiency of task performance.

In June 2024, Ekso Bionics Holdings, Inc., a US-based provider of advanced exoskeleton technologies for medical rehabilitation and industrial applications, partnered with Shepherd Center to expand the integration of its EksoNR and Ekso Indego devices across clinical and community rehabilitation settings, strengthen training programs, and improve patient mobility outcomes. Shepherd Center is a US-based rehabilitation hospital that provides comprehensive clinical care, research, and support services for individuals with spinal cord and brain injuries, stroke, multiple sclerosis, traumatic amputations, and other complex neurological conditions.

Major companies operating in the wearable robotic exoskeleton market are Lockheed Martin Corporation, Mitsubishi Heavy Industries, Ltd., Comau LLC, Shanghai Fourier Intelligence Co., Ltd., Hocoma AG (a DIH International Ltd. company), Myomo, Inc., Cyberdyne Inc., Sarcos Technology and Robotics Corporation, ATOUN Inc., Ekso Bionics Holdings, Inc., BioServo Technologies AB, Daiya Industry Co., Ltd., ReWalk Robotics Ltd., Skelex AG, Focal Meditech B.V., B-Temia Inc., Technaid S.L., Rex Bionics Ltd., Innervo Labs Inc., Harmonic Bionics, Inc., Gogoa Mobility Robots S.L., Bionik Laboratories Corp., P&S Mechanics Co., Ltd., Skeletonics Co., Ltd.

North America was the largest region in the wearable robotic exoskeleton market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable robotic exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the wearable robotic exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 1-3 business days.